Recilisib sodium - CAS 922139-31-9

Recilisib, also known as ON 01210.Na, is a radioprotectant, which modifys cell cycle distribution patterns in cancer cells subjected to radiation therapy, and it has been identified as a potential candidate for radiation protection studies. It appears that Recilisib radioprotective mechanisms involve prevention of p53-dependent and independent radiation-induced apoptosis.

Akt, Others, PI3K

Cytoskeletal Signaling, PI3K/Akt/mTOR signaling, Others

922099

C16H13ClNaO4S

359.78

[Na].OC(=O)c1ccc(\C=C\S(=O)(=O)Cc2ccc(Cl)cc2)cc1

-20°C

Ice Packs

Small Compound